Eris Lifesciences transfers ₹861.91 crore holdings to subsidiary as part of internal restructuring
Eris Lifesciences Ltd on Thursday (March 6) said it has transferred its 100% holdings in Eris Oaknet Healthcare Private Ltd (EOHPL) and Aprica Healthcare Ltd (AHL) to Eris Therapeutics Ltd (ETL), a wholly-owned subsidiary, as part of its internal restructuring.